A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia

NCT00482703 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Myeloid Leukemia, Chronic

Interventions

DRUG: Dasatinib
DRUG: dasatinib

Sponsor

Bristol-Myers Squibb